Latest Health News
Guinea-Bissau Halts Controversial U.S.-Funded Hepatitis B Vaccine Trial in Infants
Guinea-Bissau shut down a U.S. CDC-backed study testing hepatitis B vaccine timing in newborns after WHO chief Tedros condemned it as unethical, with only half of infants receiving the shot at birth. Critics linked it to autism theories, prompting the foreign minister to declare it over. The decision followed alarms from scientists, health bodies, and U.S. lawmakers.
New Blood Test 'Clock' Predicts Alzheimer's Symptom Onset
A Nature Medicine study reveals a blood test tracking p-tau217 protein levels to detect Alzheimer's early and estimate symptom start. This could enable long-dreamed early intervention for the disease.
Washington Post coverage emphasizes its potential impact.
Science Publishes Approach for Universal Vaccine Development
A provocative paper in Science outlines a universal vaccine activating the immune system against multiple viruses, not just one. BBC reports caution needed amid hype around such breakthroughs.
It aims to put the entire immune system on high alert.
FDA Approves Novocure's Optune Pax for Pancreatic Cancer
Novocure's wearable device delivers tumor treating fields (TTFields) with chemotherapy for locally advanced pancreatic cancer, targeting fast-growing cells non-invasively. This first-of-its-kind approval highlights needs for research and early detection.
It avoids harsh side effects of other treatments.
AI Tool from Valar Labs Predicts Pancreatic Cancer Chemo Response
A Journal of Clinical Oncology study validates an AI diagnostic analyzing pathology slides to predict metastatic pancreatic cancer response to FOLFIRINOX or gemcitabine/nab-paclitaxel. Developed using PanCAN data, it aids treatment decisions.
This advances precision medicine in oncology.
Deadly H5N1 Bird Flu Confirmed in California Elephant Seals
H5N1 virus, devastating South American seals, found in seven weaned pups at Año Nuevo State Park by UC Davis and UC Santa Cruz researchers. Confirmed by USDA lab, it ravages global wildlife and livestock.
Los Angeles Times reports first U.S. West Coast seal cases.
Flu Season 2025-26 Expected to Linger into Spring
Health experts warn influenza A will extend into warmer months, tracking historical trends. Dr. Michael Glazier advises preparation as the aggressive strain dominates.
Fox News highlights ongoing risks.
AHA Warns 6 in 10 Women May Have CVD Risk Factors by 2050
American Heart Association predicts rises in hypertension and obesity among women without better prevention, affecting even youth. Early detection tools are crucial.
ABC News covers the scientific statement.
US Multistate Infant Botulism Outbreak Linked to Powdered Formula
Public Health Alerts reports dozens of infant cases tied to a specific formula product. NEJM Evidence and CIDRAP collaboration provides expert-reviewed evidence.
It fills gaps in reliable outbreak data.
Merck's DOR/ISL HIV Two-Drug Regimen Shows Phase 3 Efficacy at CROI 2026
Late-breaking data from three trials show non-inferior viral suppression vs. standards like BIC/FTC/TAF, with similar safety. Presented at CROI, it offers once-daily option without INSTI for untreated adults.
Islatravir anchors potential daily/weekly regimens.
Canada Announces Major Investment in Cancer Prevention Research
Minister of Health Marjorie Michel reveals funding from CIHR, Terry Fox Institute, and partners at Princess Margaret Cancer Centre. Initiative partners include Canadian Cancer Society and Japan Agency.
Media availability follows the February 26 announcement.
Bolivia Faces Chikungunya Outbreak, Vaccination Options Highlighted
East/Central/South African genotype outbreak prompts calls for vaccination strategies. US CDC notes implications for February 2027 travel advisories.
Vax-Before-Travel emphasizes proactive measures.